YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

Abstract

Plasma YKL-40 was significantly increased in patients with STEMI and stable CAD. Further studies will define the role of YKL-40 as a clinically useful marker for myocardial ischemia, remodelling and maybe prognosis.